市場調查報告書
商品編碼
1210916
牛呼吸系統疾病 (BRD) 治療全球市場規模調查和預測:按治療、疾病和地區進行的分析,2022-2029 年Global Bovine Respiratory Disease Treatment Market Size study & Forecast, by Material Treatment Type, Disease Type, and Regional Analysis, 2022-2029 |
牛呼吸道疾病藥物是指世界範圍內發生在牛身上的常見疾病。
包括傳染性牛鼻氣管炎 (IBR)、牛呼吸道合胞病毒 (BRSV)、牛病毒性腹瀉 (BVD) 和 3 型副流感病毒 (PI-3)。 受牛肉消費量增加、牛呼吸道疾病發病率上升等因素影響,治療牛呼吸道疾病的藥物市場正在擴大
根據2022年9月發表的一篇題為《世界牛肉消費量》的文章,根據國家排名(美國農業部),2020年世界牛肉消費量增加1473.4億磅。 美國將在 2020 年成為牛肉消費量最高的國家,其次是中國、歐盟、巴西和印度。
另一方面,越來越多的白喉病例和市場參與者增加的研發活動為市場創造了有利可圖的機會。 然而,熟練獸醫的短缺將阻礙整個 2022-2029 年預測期內的市場增長。
全球牛呼吸道疾病治療市場研究考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於牛肉產量和消費量的增加、BRD 病例的增加以及對牛呼吸道治療的認識不斷提高,北美在收入方面佔據了市場主導地位。 另一方面,由於 BRD 監控產品的技術進步不斷增加以及市場參與者的滲透率不斷提高等因素,預計北美地區在預測期內將出現顯著增長。
這項研究的目的是定義近年來各個細分市場和國家的市場規模,並預測他們在未來幾年的價值。 本報告旨在捕捉被調查國家行業的定性和定量方面的情況。
它還提供了關鍵方面的詳細信息,例如決定市場未來增長的驅動因素和挑戰。 此外,它還包含供利益相關者投資的微觀市場潛在機會,以及對主要參與者的競爭格局和產品供應的深入分析。
Global Bovine Respiratory Disease Treatment Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Bovine Respiratory Disease Treatment refers to the common diseases occur to cattle globally. It includes infectious bovine rhinotracheitis (IBR), bovine respiratory syncytial virus (BRSV), bovine viral diarrhea (BVD), and parainfluenza type-3 virus (PI-3). The Bovine Respiratory Disease Treatment market is expanding because of factors such as the growing consumption of beef and rising incidences of bovine respiratory diseases
According to the article published in September 2022, titled "World Beef Consumption: Ranking of Countries (USDA)," global beef consumption stood at 147.34 billion pounds in 2020. The United States consumed the most beef in 2020, followed by China, the European Union, Brazil, and India.
Whereas, rising cases of Diphtheria and growing R&D activities by market players create lucrative opportunities for the market. However, the lack of skilled veterinarians hampers the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Bovine Respiratory Disease Treatment Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the increasing production and consumption of bovine meat and rising cases of BRD, and increasing awareness of bovine respiratory treatment Whereas North America is expected to grow significantly during the forecast period, owing to factors such as increasing technological advances in products to monitor BRD and growing penetration of market players etc. in the forecast period
Major market players included in this report are:
Bimeda
Boehringer Ingelheim GmbH
Ceva
Elanco
Krka UK Ltd
Merial
Merck & Co. Inc.
Vetoquinol
Virbac
Zoetis Inc.
Recent Developments in the Market:
Global Bovine Respiratory Disease Treatment Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Treatment, Disease, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Treatment:
Vaccines,
Antibiotics,
NSAIDs,
Immunomodulators,
Other Treatment Types
By Disease:
Lower Respiratory Tract Infections,
Upper Respiratory Tract Infections,
Diphtheria
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable